Skip to main content

The Science of Longevity: Revolutionizing Medicine by Slowing Aging

Big ThinkNovember 3, 202513 min85,809 views
26 connections·40 entities in this video→

Rethinking Longevity and Healthspan

  • πŸ’‘ Longevity science is not about immortality but about increasing healthspan, the period of life free from disease, pain, and memory loss.
  • πŸš€ The economic benefits of slowing aging are immense, with one year of slowed aging potentially worth $38 trillion by keeping people healthier and more active.
  • πŸ”¬ The speaker, Dr. Andrew Steele, shifted from physics to longevity science after observing the exponential increase in the risk of death with age.

Understanding Biological Age

  • πŸ“Š Chronological age is based on birthdays, while biological age reflects the actual aging of our cells and body, measurable through factors like grip strength or epigenetic tests.
  • 🧬 The epigenome, a layer of chemical markers on DNA, changes with age and can be used to estimate biological age, though its exact causal relationship to aging is still being researched.
  • ⚠️ Scientists have identified 12 hallmarks of aging, fundamental biological processes that contribute to age-related decline.

Emerging Longevity Interventions

  • 🎯 Senolytic drugs are designed to remove senescent (old) cells, which accumulate with age and drive diseases, showing promise in making mice biologically younger and healthier.
  • ✨ Cellular reprogramming, inspired by Yamanaka factors, aims to reset the biological clock within cells, potentially reversing aging without turning cells into undifferentiated stem cells.
  • πŸ’Š Repurposing existing drugs like metformin (for diabetes) and rapamycin (initially antifungal) are considered quick short-term wins due to their known safety profiles and demonstrated effects on slowing aging in animal models.

Future Possibilities and Ethical Considerations

  • 🧬 Gene therapy, such as transiently activating Yamanaka factors, holds potential for human longevity treatments, with significant investment from companies like Altos Labs.
  • πŸ§ͺ While epigenetic reprogramming is promising, it doesn't address all hallmarks of aging, such as DNA mutations or extracellular damage.
  • πŸ’¬ Ethical questions surrounding longevity, such as overpopulation and boredom, are often raised, but Steele argues longevity science is simply an extension of modern medicine.
  • πŸ’° Despite aging being the leading cause of death globally, funding for longevity research is surprisingly low, highlighting the need for large-scale projects akin to the Human Genome Project.
  • πŸ€– The integration of AI and systems biology is crucial for understanding the complex biological processes of aging, requiring massive datasets and investment to build predictive models of human biology.
Knowledge graph40 entities Β· 26 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
40 entities
Chapters7 moments

Key Moments

Transcript50 segments

Full Transcript

Topics16 themes

What’s Discussed

Longevity ScienceHealthspanBiological AgeChronological AgeEpigeneticsHallmarks of AgingSenescent CellsSenolytic DrugsCellular ReprogrammingYamanaka FactorsMetforminRapamycinAutophagyGene TherapyArtificial IntelligenceSystems Biology
Smart Objects40 Β· 26 links
ProductsΒ· 5
ConceptsΒ· 25
CompaniesΒ· 2
PeopleΒ· 4
MediasΒ· 3
LocationΒ· 1